RepliCel Free Cash Flow Yield vs Price To Sales Ratio Analysis

RP Stock

CAD 0.06 0.00 0.00%

RepliCel Life financial indicator trend analysis is much more than just breaking down RepliCel Life Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether RepliCel Life Sciences is a good investment. Please check the relationship between RepliCel Life Free Cash Flow Yield and its Price To Sales Ratio accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Free Cash Flow Yield vs Price To Sales Ratio

Free Cash Flow Yield vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of RepliCel Life Sciences Free Cash Flow Yield account and Price To Sales Ratio. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between RepliCel Life's Free Cash Flow Yield and Price To Sales Ratio is -0.23. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of RepliCel Life Sciences, assuming nothing else is changed. The correlation between historical values of RepliCel Life's Free Cash Flow Yield and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of RepliCel Life Sciences are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Free Cash Flow Yield i.e., RepliCel Life's Free Cash Flow Yield and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

-0.23

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing RepliCel Life Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on RepliCel Life sales, a figure that is much harder to manipulate than other RepliCel Life Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Most indicators from RepliCel Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into RepliCel Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

At this time, RepliCel Life's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 5.74 in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 1.6 M in 2024.

RepliCel Life fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Non Currrent Assets Other	Other Assets	Non Current Liabilities Total	Other Current Assets	Other Liab	Net Tangible Assets	Property Plant Equipment	Short Term Investments
Total Assets		0.45	-0.13	0.43	0.24	-0.8	0.02	-0.22	0.8	0.02	0.98	0.15	-0.12	0.32	-0.17	0.99	0.14	0.05	-0.33	0.18	-0.29	-0.3	-0.11	0.25	0.1	0.05
Short Long Term Debt Total	0.45		-0.62	0.77	0.73	-0.33	0.51	-0.29	0.33	-0.4	0.47	-0.43	-0.7	0.49	-0.73	0.47	-0.17	-0.39	-0.41	-0.13	-0.87	-0.69	-0.57	0.72	0.6	0.49
Total Current Liabilities	-0.13	-0.62		-0.87	-0.87	0.14	-0.92	0.73	-0.08	0.76	-0.27	0.86	0.95	-0.34	0.94	-0.19	0.47	0.82	-0.26	0.75	0.79	0.87	0.89	-0.94	-0.94	-0.89
Total Stockholder Equity	0.43	0.77	-0.87		0.89	-0.38	0.84	-0.59	0.32	-0.77	0.55	-0.66	-0.89	0.49	-0.94	0.5	-0.38	-0.72	0.05	-0.56	-0.91	-0.91	-0.79	0.98	0.88	0.8
Property Plant And Equipment Net	0.24	0.73	-0.87	0.89		-0.24	0.87	-0.53	0.17	-0.77	0.39	-0.74	-0.9	0.58	-0.89	0.31	-0.31	-0.79	-0.08	-0.71	-0.89	-0.87	-0.83	0.9	0.95	0.9
Net Debt	-0.8	-0.33	0.14	-0.38	-0.24		-0.16	0.19	-0.99	0.05	-0.79	-0.01	0.14	0.03	0.17	-0.8	-0.1	0.09	0.21	-0.03	0.24	0.33	0.19	-0.24	-0.16	-0.05
Retained Earnings	0.02	0.51	-0.92	0.84	0.87	-0.16		-0.7	0.1	-0.79	0.19	-0.81	-0.89	0.27	-0.88	0.1	-0.43	-0.94	0.29	-0.87	-0.73	-0.8	-0.89	0.91	0.96	0.92
Accounts Payable	-0.22	-0.29	0.73	-0.59	-0.53	0.19	-0.7		-0.17	0.53	-0.34	0.49	0.56	-0.18	0.54	-0.26	0.05	0.74	-0.4	0.69	0.32	0.45	0.56	-0.63	-0.65	-0.67
Cash	0.8	0.33	-0.08	0.32	0.17	-0.99	0.1	-0.17		0.05	0.77	0.06	-0.07	-0.08	-0.1	0.79	0.14	-0.04	-0.22	0.1	-0.18	-0.23	-0.14	0.18	0.09	-0.03
Non Current Assets Total	0.02	-0.4	0.76	-0.77	-0.77	0.05	-0.79	0.53	0.05		-0.16	0.59	0.71	-0.48	0.79	-0.09	0.14	0.73	-0.13	0.75	0.71	0.73	0.57	-0.81	-0.82	-0.81
Cash And Short Term Investments	0.98	0.47	-0.27	0.55	0.39	-0.79	0.19	-0.34	0.77	-0.16		0.02	-0.24	0.39	-0.29	0.99	0.12	-0.12	-0.29	-0.03	-0.38	-0.4	-0.24	0.39	0.27	0.22
Net Receivables	0.15	-0.43	0.86	-0.66	-0.74	-0.01	-0.81	0.49	0.06	0.59	0.02		0.87	-0.1	0.82	0.1	0.66	0.76	-0.42	0.7	0.63	0.73	0.85	-0.76	-0.84	-0.75
Common Stock Shares Outstanding	-0.12	-0.7	0.95	-0.89	-0.9	0.14	-0.89	0.56	-0.07	0.71	-0.24	0.87		-0.41	0.97	-0.18	0.61	0.79	-0.18	0.66	0.88	0.93	0.9	-0.94	-0.94	-0.89
Other Stockholder Equity	0.32	0.49	-0.34	0.49	0.58	0.03	0.27	-0.18	-0.08	-0.48	0.39	-0.1	-0.41		-0.41	0.37	0.11	-0.24	-0.43	-0.21	-0.55	-0.46	-0.14	0.43	0.42	0.57
Total Liab	-0.17	-0.73	0.94	-0.94	-0.89	0.17	-0.88	0.54	-0.1	0.79	-0.29	0.82	0.97	-0.41		-0.23	0.55	0.76	-0.16	0.62	0.93	0.94	0.87	-0.98	-0.92	-0.85
Total Current Assets	0.99	0.47	-0.19	0.5	0.31	-0.8	0.1	-0.26	0.79	-0.09	0.99	0.1	-0.18	0.37	-0.23		0.14	-0.01	-0.32	0.1	-0.35	-0.36	-0.15	0.33	0.17	0.13
Short Term Debt	0.14	-0.17	0.47	-0.38	-0.31	-0.1	-0.43	0.05	0.14	0.14	0.12	0.66	0.61	0.11	0.55	0.14		0.38	-0.51	0.25	0.4	0.54	0.64	-0.47	-0.42	-0.35
Common Stock	0.05	-0.39	0.82	-0.72	-0.79	0.09	-0.94	0.74	-0.04	0.73	-0.12	0.76	0.79	-0.24	0.76	-0.01	0.38		-0.31	0.9	0.61	0.68	0.81	-0.81	-0.89	-0.87
Non Currrent Assets Other	-0.33	-0.41	-0.26	0.05	-0.08	0.21	0.29	-0.4	-0.22	-0.13	-0.29	-0.42	-0.18	-0.43	-0.16	-0.32	-0.51	-0.31		-0.36	0.2	-0.04	-0.24	0.15	0.19	0.18
Other Assets	0.18	-0.13	0.75	-0.56	-0.71	-0.03	-0.87	0.69	0.1	0.75	-0.03	0.7	0.66	-0.21	0.62	0.1	0.25	0.9	-0.36		0.43	0.54	0.72	-0.67	-0.83	-0.85
Non Current Liabilities Total	-0.29	-0.87	0.79	-0.91	-0.89	0.24	-0.73	0.32	-0.18	0.71	-0.38	0.63	0.88	-0.55	0.93	-0.35	0.4	0.61	0.2	0.43		0.91	0.75	-0.9	-0.81	-0.73
Other Current Assets	-0.3	-0.69	0.87	-0.91	-0.87	0.33	-0.8	0.45	-0.23	0.73	-0.4	0.73	0.93	-0.46	0.94	-0.36	0.54	0.68	-0.04	0.54	0.91		0.8	-0.92	-0.87	-0.8
Other Liab	-0.11	-0.57	0.89	-0.79	-0.83	0.19	-0.89	0.56	-0.14	0.57	-0.24	0.85	0.9	-0.14	0.87	-0.15	0.64	0.81	-0.24	0.72	0.75	0.8		-0.87	-0.89	-0.79
Net Tangible Assets	0.25	0.72	-0.94	0.98	0.9	-0.24	0.91	-0.63	0.18	-0.81	0.39	-0.76	-0.94	0.43	-0.98	0.33	-0.47	-0.81	0.15	-0.67	-0.9	-0.92	-0.87		0.94	0.86
Property Plant Equipment	0.1	0.6	-0.94	0.88	0.95	-0.16	0.96	-0.65	0.09	-0.82	0.27	-0.84	-0.94	0.42	-0.92	0.17	-0.42	-0.89	0.19	-0.83	-0.81	-0.87	-0.89	0.94		0.95
Short Term Investments	0.05	0.49	-0.89	0.8	0.9	-0.05	0.92	-0.67	-0.03	-0.81	0.22	-0.75	-0.89	0.57	-0.85	0.13	-0.35	-0.87	0.18	-0.85	-0.73	-0.8	-0.79	0.86	0.95

Click cells to compare fundamentals

RepliCel Life Account Relationship Matchups

RepliCel Life fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	505.5K	421.0K	591.8K	798.2K	718.4K	898.5K
Total Current Liabilities	1.6M	2.2M	1.7M	2.1M	2.4M	2.5M
Total Stockholder Equity	(4.4M)	(5.1M)	(6.8M)	(5.9M)	(5.3M)	(5.1M)
Property Plant And Equipment Net	6.0K	4.4K	3.3K	2.4K	2.2K	2.1K
Net Debt	425.4K	41.7K	(186.9K)	(372.1K)	(334.9K)	(318.1K)
Retained Earnings	(36.6M)	(38.2M)	(42.2M)	(43.0M)	(38.7M)	(36.7M)
Accounts Payable	640.3K	1.3M	602.0K	817.9K	940.6K	473.1K
Cash	23.9K	34.4K	221.2K	413.0K	475.0K	486.0K
Non Current Assets Total	272.2K	235.3K	198.8K	162.5K	146.3K	139.0K
Cash And Short Term Investments	52.7K	51.6K	238.4K	430.3K	494.8K	652.7K
Net Receivables	51.9K	63.6K	61.2K	82.2K	94.5K	99.2K
Common Stock Shares Outstanding	24.1M	27.0M	32.5M	37.8M	43.4M	45.6M
Liabilities And Stockholders Equity	505.5K	421.0K	591.8K	798.2K	718.4K	898.5K
Other Stockholder Equity	4.6M	4.6M	5.1M	5.4M	6.2M	7.7M
Total Liab	4.9M	5.5M	7.4M	6.7M	7.7M	8.1M
Total Current Assets	233.2K	185.7K	393.0K	635.7K	731.0K	793.7K
Common Stock	27.5M	28.5M	30.3M	31.7M	36.4M	19.0M
Other Current Liab	107.3K	517.8K	106.6K	211.8K	243.6K	260.9K
Other Assets	301.6K	266.2K	230.8K	195.5K	224.8K	158.4K
Non Current Liabilities Total	3.4M	3.2M	5.8M	4.6M	5.3M	5.6M
Other Current Assets	128.7K	70.5K	93.4K	123.2K	141.7K	148.8K
Net Tangible Assets	(1.9M)	(4.4M)	(5.1M)	(6.8M)	(6.2M)	(5.9M)
Property Plant Equipment	8.2K	6.0K	4.4K	3.3K	2.9K	2.8K
Net Invested Capital	(2.9M)	(5.0M)	(6.8M)	(5.9M)	(5.3M)	(5.6M)
Net Working Capital	(1.2M)	(2.1M)	(1.3M)	(1.4M)	(1.3M)	(1.4M)
Capital Stock	29.0M	28.5M	30.3M	31.7M	36.4M	32.6M

Pair Trading with RepliCel Life

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RepliCel Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RepliCel Life will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to RepliCel Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace RepliCel Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back RepliCel Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling RepliCel Life Sciences to buy it.

The correlation of RepliCel Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as RepliCel Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if RepliCel Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for RepliCel Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for RepliCel Stock analysis

When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.

	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios

Please note, there is a significant difference between RepliCel Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if RepliCel Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RepliCel Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

RepliCel Free Cash Flow Yield vs Price To Sales Ratio Analysis

Free Cash Flow Yield vs Price To Sales Ratio

Free Cash Flow Yield vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Free Cash Flow Yield

Price To Sales Ratio

RepliCel Life fundamental ratios Correlations

RepliCel Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

RepliCel Life fundamental ratios Accounts

Pair Trading with RepliCel Life

Complementary Tools for RepliCel Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.98	Total Assets
Net Tangible Assets	+ 0.98	Total Stockholder Equity
Total Liab	+ 0.97	Common Stock Shares Outstanding
Property Plant Equipment	+ 0.96	Retained Earnings

Cash	- 0.99	Net Debt
Net Tangible Assets	- 0.98	Total Liab
Property Plant Equipment	- 0.94	Common Stock Shares Outstanding
Net Tangible Assets	- 0.94	Common Stock Shares Outstanding
Common Stock	- 0.94	Retained Earnings
Total Liab	- 0.94	Total Stockholder Equity